We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Red Tide Toxins” Leave Beachgoers Breathless

By HospiMedica staff writers
Posted on 02 Feb 2007
An ecologic phenomenon known as Florida red tide can impact respiratory function and increase respiratory symptoms in patients with asthma, according to a new study.

Researchers from the Rosenstiel School of Marine and Atmospheric Science at the University of Miami (FL, USA) and other institutions evaluated the exposures and effects of aerosolized Florida red tide toxins in 97 subjects with asthma. More...
The participants spent at least one hour at the Sarasota (FL, USA) Siesta Beach during active Karenia brevis--an ocean organism--bloom (exposure period) and during a period when there was no bloom (nonexposure period). Detailed baseline information was collected, and all participants underwent pre- and post-beach evaluations, including medical history questionnaires, nasal swab sampling, and lung function testing (spirometry). The researchers also collected water and air samples and monitored air temperature, relative humidity, and wind speed and direction.

During exposure periods, participants reported a significant increase in respiratory symptoms, predominantly chest tightness, and differences were measured objectively on lung function testing. In contrast, no significant differences were observed between pre- and post- beach symptoms or spirometry during nonexposure periods. The study appears in the January 2007 issue of Chest.

"In the normal population, inhaled aerosolized red tide toxins can lead to eye irritation, rhinorrhea, nonproductive cough, and wheezing. However, these symptoms usually subside after leaving beach areas,” said lead author Lora E. Fleming, M.D., Ph.D. "Our study shows that Florida red tide toxins may have a greater impact on patients with asthma, who experienced respiratory problems.”

Florida red tide is an algae bloom caused by a species of dinoflagellate known as K brevis that occur almost annually along Florida waters. The density of these organisms during a bloom can exceed tens of millions of cells per liter of seawater, and often discolor the water a deep reddish-brown hue. The most conspicuous effects of red tides are the associated wildlife mortalities among marine and coastal species of fish, birds, marine mammals, and other organisms, caused by exposure to a potent neurotoxin produced naturally by K brevis called brevetoxin.



Related Links:
University of Miami

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.